Seoul, Korea, Aug 3: — Mezzion Pharma Co., Ltd. today announced positive results from a new in vivo study of…
Read MoreBusiness Micro
News Stories
Global Grace Cancer Run 2026: 9th Edition announced
Hyderabad, Aug 01: The 9th Edition of Quambiant’s Global Grace Cancer Run 2026, powered by Evernorth Health Services, was formally…
Read MoreIndia Seeks Global Regulatory Unity to Boost Access to Quality Medicines
New Delhi, July 31: India has called for closer collaboration among medicine regulators worldwide to strengthen global healthcare systems, improve…
Read MoreAyush Sector Gets AI Boost as Ministry Partners with IndiaAI for Digital Transformation
New Delhi, July 31: The Ministry of Ayush has partnered with IndiaAI under the Ministry of Electronics and Information Technology…
Read MoreSungkyunkwan University Team First to Show That Immune-Cell Timing Determines Glioblastoma Treatment Response
July 30: A joint research team led by Professor Sungsu Park of Sungkyunkwan University and Professor Sun-Ha Paek of Seoul…
Read MoreNPPA Sets Prices for 3,845 Medicines, Strengthening Affordable Healthcare Access
New Delhi, July 28: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 3,845 new medicines, a…
Read MoreIndia Aims to Build Global Pharma Hub Through Innovation: Piyush Goyal
New Delhi, July 28: The government is committed to strengthening India’s pharmaceutical sector by promoting innovation, research, and global competitiveness,…
Read MorePreventive Care and HPV Vaccination Key to Ending Cervical Cancer
New Delhi, July 28: The HPV vaccine can play a significant role in preventing cervical cancer and reducing the global…
Read MoreIndia Accelerates Hepatitis Elimination Mission with Expanded Free Testing and Treatment Services
New Delhi, July 27: India is stepping up efforts to eliminate viral hepatitis as a public health threat by 2030…
Read MoreIndia’s Pharma and Healthcare Deals Hold Strong at Dollar 13.9 Billion in Q2 2026
July 23: India’s pharmaceutical and healthcare sectors continued to attract strong investor interest, with deal activity remaining resilient at $13.9…
Read More